• 제목/요약/키워드: CpG

검색결과 920건 처리시간 0.027초

아토피 피부염 동물모델에서 피부에 도포한 한약 복합추출물의 염증 억제 효과 (Topical Application of Herbal-mixed Extract on back skin suppresses inflammation in Ovalbumin-induced Atopic Dermatitis)

  • 조희찬;설현철;김순례;최한석;신용철;고성규
    • 대한예방한의학회지
    • /
    • 제15권3호
    • /
    • pp.163-178
    • /
    • 2011
  • Objective : This study is conducted to evaluate the efficiency of ethanol extracts of 4 mixed herbs(CP001 or CP002) on mouse model of atopic dermatitis induced by ovalbumin. Methods : Female BALB/c mice were internally sensitized with ovalbumin($20{\mu}g$) plus aluminum hydroxide hydrate(4mg) once per week. After 3 weeks, they were dermally challenged with patches containing ovalbumin ($100{\mu}g$) plus aluminum hydroxide hydrate(20mg) every other day for 3 weeks. After induction of atopic dermatitis, mice back skin were gently rubbed with CP001 or CP002(200mg/$m{\ell}$, $100{\mu}{\ell}$) for two weeks(every 2 days). Results : In CP001 or CP002 treated group, there was a remarkable reduction in infiltration of eosinophils on the skin areas and diminution of mast cells and total T cells in blood samples as compared with control group. Cutaneous expressions of interleukin-13, 17 were also decreased by CP001 or CP002. Moreover, blood immunoglobulin E level was decreased by drug administration while there was no decrease in OVA sensitization group. Conclusion : In summary, our result shows that herbal extracts(CP001 and CP002) could be potential candidates for the treatment of chronic atopic dermatitis.

Methylation of CpG Islands in the Rat 7-dehydrocholesterol Reductase Promoter Suppresses Transcriptional Activation

  • Kim, Jai-Hyun;Hwang, Eun-Ha;Park, Hye-Jung;Paik, Young-Ki;Shim, Yhong-Hee
    • Molecules and Cells
    • /
    • 제19권2호
    • /
    • pp.279-282
    • /
    • 2005
  • In mammals, 7-dehydrocholesterol reductase (Dhcr7) is the terminal enzyme in cholesterol biosynthesis. We previously reported that the Dhcr7 proximal promoter (-179 to +1), which contains CpG islands, is responsible for sterol-mediated expression of the rat gene. In the present study, we examined whether methylation of this region affects the transcriptional activity of the Dhcr7 gene. In vitro DNA methylation of the Dhcr7 promoter and luciferase-reporter assays showed that DNA methylation of the CpG islands suppressed transcription. Furthermore, treatment of the methylated Dhcr7 promoter with the demethylating agent, 5-aza-2'-deoxycytidine (5-Aza-CdR), reversed the suppression of promoter activity. These results indicate that methylation of the CpG islands is an important transcriptional regulatory mechanism in the Dhcr7 promoter.

Dual effects of a CpG-DNAzyme targeting mutant EGFR transcripts in lung cancer cells: TLR9 activation and EGFR downregulation

  • Jang, Dahye;Baek, Yu Mi;Park, Hanna;Hwang, Yeo Eun;Kim, Dong-Eun
    • BMB Reports
    • /
    • 제51권1호
    • /
    • pp.27-32
    • /
    • 2018
  • Non-small-cell lung cancer (NSCLC) is commonly caused by a mutation in the epidermal growth factor receptor (EGFR) and subsequent aberrant EGFR signaling with uncontrolled kinase activity. A deletion mutation in EGFR exon 19 is frequently observed in EGFR gene mutations. We designed a DNAzyme to suppress the expression of mutant EGFR by cleaving the mutant EGFR mRNA. The DNAzyme (named Ex19del Dz) specifically cleaved target RNA and decreased cancer cell viability when transfected into gefitinib-resistant lung cancer cells harboring EGFR exon 19 deletions. The DNAzyme decreased EGFR expression and inhibited its downstream signaling pathway. In addition to EGFR downregulation, Ex19del Dz containing CpG sites activated Toll-like receptor 9 (TLR9) and its downstream signaling pathway via p38 kinase, causing an immunostimulatory effect on EGFR-mutated NSCLC cells. Thus, dual effects of this DNAzyme harboring the CpG site, such as TLR9 activation and EGFR downregulation, leads to apoptosis of EGFR-mutated NSCLC cells.

Nitrogen allocation of Gracilaria tikvahiae grown in urbanized estuaries of Long Island Sound and New York City, USA: a preliminary evaluation of ocean farmed Gracilaria for alternative fish feeds

  • Johnson, Ronald B.;Kim, Jang K.;Armbruster, Lisa C.;Yarish, Charles
    • ALGAE
    • /
    • 제29권3호
    • /
    • pp.227-235
    • /
    • 2014
  • The red seaweed, Gracilaria tikvahiae McLachlan, was cultivated in open water farms in urbanized estuaries of Long Island Sound (26-30 psu of salinity) and New York City (20-25 psu), USA in 2011. Plants were harvested monthly from summer (August, $24^{\circ}C$) to fall (November, $13^{\circ}C$) and analyzed for total nitrogen, protein, and amino acid content. On a dry matter (DM) basis, nitrogen and protein significantly increased over the harvest period until October and then plateaued. Nitrogen increased from $22{\pm}1g\;kg^{-1}$ DM in August to $39{\pm}3g\;kg^{-1}$ DM in October (p < 0.001). Protein increased from $107{\pm}13g\;kg^{-1}$ DM in August to $196{\pm}5g\;kg^{-1}$ DM in November (p < 0.001). With two exceptions, amino acid concentrations expressed on a crude protein (CP) basis were similar over the harvest period. Essential amino acids accounted for $48{\pm}1%$ of all amino acids present with lysine and methionine averaging $56{\pm}2g\;kg^{-1}$ CP and $18{\pm}1g\;kg^{-1}$ CP, respectively. Histidine was underrepresented among essential amino acids and averaged $13{\pm}1g\;kg^{-1}$ CP. Taurine ranged from 2.1 to $3.2g\;kg^{-1}$ DM. With its moderate levels of lysine, methionine and taurine, ocean farmed G. tikvahiae has the potential of overcoming many nutrient deficiencies currently associated with terrestrial plant ingredients in alternative feeds for fish and shrimp.

Mouse에서 CLA의 투여가 면역성 증진에 미치는 영향 (CLA Treatment Effect on Immunsuppressive Effect of Corticosteroid in Mouse)

  • 박종국;김진영;이병한;임좌진;정병현
    • 한국임상수의학회지
    • /
    • 제20권1호
    • /
    • pp.79-85
    • /
    • 2003
  • Dietary conjugated linoleic acid(CLA) has been shown to affect immune function. Thus, the objective of this study was to investigate the effects of CLA on the mice that treated prednisone. Mice were randomized into 6 groups and fed diet containing either 0(control, P), 0.5%(CLA1, CP1) or 1.5%(CLA2, CP2) CLA for Sweets. Before 1 week of finishing diet supplement CP1, CP2, and P group treated the prednisone by subcutaneous injection. The levels of serum immunoglobulin A, G, E, gut lumen s-IgA, MLN immunoglobulin A, body weight, mucosal protein was compared. The level of serum IgA in CLA1, CLA2, CP1, and CP2 group increased, while which of P group was decreased. The level of serum IgG in CLA 1 group increased, while which of the other group no differences. Serum IgE level showed no difference and the immunoglobulin production in MLN lymphocyte in CLA 1 group increased. The level of gut lumen s-IgA in P group showed decreased, while which of the other group showed no differences. These results support the view that CLA supplement partially enhance the cell-mediated immunity and overcome the immunosuppressive effect of prednisone.

Cloning of Notl-linked DNA Detected by Restriction Landmark Genomic Scanning of Human Genome

  • Kim Jeong-Hwan;Lee Kyung-Tae;Kim Hyung-Chul;Yang Jin-Ok;Hahn Yoon-Soo;Kim Sang-Soo;Kim Seon-Young;Yoo Hyang-Sook;Kim Yong-Sung
    • Genomics & Informatics
    • /
    • 제4권1호
    • /
    • pp.1-10
    • /
    • 2006
  • Epigenetic alterations are common features of human solid tumors, though global DNA methylation has been difficult to assess. Restriction Landmark Genomic Scanning (RLGS) is one of technology to examine epigenetic alterations at several thousand Notl sites of promoter regions in tumor genome. To assess sequence information for Notl sequences in RLGS gel, we cloned 1,161 unique Notl-linked clones, compromising about 60% of the spots in the soluble region of RLGS profile, and performed BLAT searches on the UCSC genome server, May 2004 Freeze. 1,023 (88%) unique sequences were matched to the CpG islands of human genome showing a large bias of RLGS toward identifying potential genes or CpG islands. The cloned Notl-loci had a high frequency (71%) of occurrence within CpG islands near the 5' ends of known genes rather than within CpG islands near the 3' ends or intragenic regions, making RLGS a potent tool for the identification of gene-associated methylation events. By mixing RLGS gels with all Notl-linked clones, we addressed 151 Notl sequences onto a standard RLGS gel and compared them with previous reports from several types of tumors. We hope our sequence information will be useful to identify novel epigenetic targets in any types of tumor genome.

Identification of Serial DNA Methylation Changes in the Blood Samples of Patients with Lung Cancer

  • Moon, Da Hye;Kwon, Sung Ok;Kim, Woo Jin;Hong, Yoonki
    • Tuberculosis and Respiratory Diseases
    • /
    • 제82권2호
    • /
    • pp.126-132
    • /
    • 2019
  • Background: The development of lung cancer results from the interaction between genetic mutations and dynamic epigenetic alterations, although the exact mechanisms are not completely understood. Changes in DNA methylation may be a promising biomarker for early detection and prognosis of lung cancer. We evaluated the serial changes in genome-wide DNA methylation patterns in blood samples of lung cancer patients. Methods: Blood samples were obtained for three consecutive years from three patients (2 years before, 1 year before, and after lung cancer detection) and from three control subjects (without lung cancer). We used the MethylationEPIC BeadChip method, which covers the 850,000 bp cytosine-phosphate-guanine (CpG) site, to conduct an epigenome-wide analysis. Significant differentially methylated regions (DMRs) were identified using p-values <0.05 in a correlation test identifying serial methylation changes and serial increase or decrease in ${\beta}$ value above 0.1 for three consecutive years. Results: We found three significant CpG sites with differentially methylated ${\beta}$ values and 7,105 CpG sites with significant correlation from control patients without lung cancer. However, there were no significant DMRs. In contrast, we found 11 significant CpG sites with differentially methylated ${\beta}$ values and 10,562 CpG sites with significant correlation from patients with lung cancer. There were two significant DMRs: cg21126229 (RNF212) and cg27098574 (BCAR1). Conclusion: This study revealed DNA methylation changes that might be implicated in lung cancer development. The DNA methylation changes may be the possible candidate target regions for the early detection and prevention of lung cancer.

Identification of a novel PARP4 gene promoter CpG locus associated with cisplatin chemoresistance

  • Hye Youn Sung;Jihye Han;Yun Ju Chae;Woong Ju;Jihee Lee Kang;Ae Kyung Park;Jung-Hyuck Ahn
    • BMB Reports
    • /
    • 제56권6호
    • /
    • pp.347-352
    • /
    • 2023
  • The protein family of poly (ADP-ribose) polymerases (PARPs) is comprised of multifunctional nuclear enzymes. Several PARP inhibitors have been developed as new anticancer drugs to combat resistance to chemotherapy. Herein, we characterized PARP4 mRNA expression profiles in cisplatin-sensitive and cisplatin-resistant ovarian cancer cell lines. PARP4 mRNA expression was significantly upregulated in cisplatin-resistant ovarian cancer cell lines, and this upregulation was associated with the hypomethylation of specific cytosine-phosphate-guanine (CpG) sites (cg18582260 and cg17117459) on its promoter. Reduced PARP4 expression was restored by treating cisplatin-sensitive cell lines with a demethylation agent, implicating the epigenetic regulation of PARP4 expression by promoter methylation. Depletion of PARP4 expression in cisplatin-resistant cell lines reduced cisplatin chemoresistance and promoted cisplatin-induced DNA fragmentation. The differential mRNA expression and DNA methylation status at specific PARP4 promoter CpG sites (cg18582260 and cg17117459) according to cisplatin responses, was further validated in primary ovarian tumor tissues. The results showed significantly increased PARP4 mRNA expressions and decreased DNA methylation levels at specific PARP4 promoter CpG sites (cg18582260 and cg17117459) in cisplatin-resistant patients. Additionally, the DNA methylation status at cg18582260 CpG sites in ovarian tumor tissues showed fairly clear discrimination between cisplatin-resistant patients and cisplatin-sensitive patients, with high accuracy (area under the curve = 0.86, P = 0.003845). Our findings suggest that the DNA methylation status of PARP4 at the specific promoter site (cg18582260) may be a useful diagnostic biomarker for predicting the response to cisplatin in ovarian cancer patients.

이온성 액체에 의한 거대억새 전처리 특성 및 리그닌의 구조적 변화 관찰 (Study on Pretreatment of Giant Miscanthus Using Ionic Liquid and Structural Change of Lignin)

  • 박신영;황혜원;장수경;최인규;최준원
    • Journal of the Korean Wood Science and Technology
    • /
    • 제43권3호
    • /
    • pp.344-354
    • /
    • 2015
  • 이온성 액체를 이용한 거대억새의 전처리 특성을 알아보기 위하여 1-ethyl-3-methylimidazolium acetate ([Emim][OAc])와 1-butyl-3-methylimidazolium acetate ([Bmim][OAc]) 두 종류의 이온성 액체로 $90^{\circ}C$, $110^{\circ}C$, $130^{\circ}C$ 세 온도조건에서 전처리를 진행하였다. 반응 온도가 높아짐에 따라 cellulose-rich product (CP)의 수율은 87.2%에서 67.6%로 점차 감소하였으며 ionic liquid lignin (ILL)의 수율은 2.2%에서 9.9%로 증가하였다. CP는 ILL에 비해 탄소함량은 낮았지만, 산소함량은 높게 나타났다. CP의 효소당화 결과 $110^{\circ}C$에서 [Emim][OAc]로 전처리하여 얻은 CP의 당화율이 56.7%로 가장 높게 나타났다. ILL의 열중량 분석 결과에 의하면 전처리 온도가 증가함에 따라 최대분해율은 점차 감소하였으며, 최대분해온도는 [Emim][OAc]로 처리한 ILL이 $274{\sim}279^{\circ}C$로 [Bmim][OAc]의 $2701{\sim}294^{\circ}C$보다 낮은 경향을 나타내었다. 전처리 온도가 $90^{\circ}C$에서 $130^{\circ}C$로 증가함에 따라 ILL 내 ${\beta}$-O-4 결합빈도는 [Emim][OAc]의 경우 $2315{\mu}mol/g$에서 $591{\mu}mol/g$으로, [Bmim][OAc]의 경우 $1936{\mu}mol/g$에서 $2478{\mu}mol/g$으로 감소하였다. ILL의 S/G ratio는 [Bmim][OAc]용액으로 $110^{\circ}C$에서 처리하였을 때 1.2로 가장 높게 나타났다.

보중익기탕가미방(補中益氣湯加味方)이 cyclophosphamide 투여로 인한 골수손상의 억제 및 회복에 미치는 영향 (Inhibiting and Repairing Effects of Bojung-ikki-tang Gamibang on Cyclophosphamide induced Bone Marrow Injuries in Rats)

  • 고흥;김동우
    • 동의생리병리학회지
    • /
    • 제19권3호
    • /
    • pp.736-742
    • /
    • 2005
  • This study was carried out to investigate the inhibiting and repairing effects of Bojung-ikki-tang Gamibang(BI-G) on the bone marrow injuries in rats. Bone marrow injury was induced by a single intraperitoneal injection of cyclophosphamide(CP)(150mg/kg). In experiment I, designed for inhibiting effect, extract of BI-G(80mg) was administrated from pre-5 days to post-5 days of CP injection. In experiment II, designed for repairing effect, extract of BI-G(80mg) was administrated after 5 days to 12 days of CP injection. Hematological and histopathological examinations were performed at 5 days after CP injection in experiment I, and at 12 days after CP injection in experiment II. In experiment I, the results were as follows ; RBC(${\times}10^6/{\mu}l$) of BI-G treated group$(8.39{\pm}0.84)$ was increased significantly compared with control group$(7.52{\pm}7.67)$. Hemoglobin(g/dl) of BI-G treated group$(13.76{\pm}1.20)$ was increased significantly compared with control group$(12.24{\pm}1.11)$. WBC(${\times}10^3/{\mu}l$) of BI-G treated group$(1.75{\pm}0.41)$ was increased significantly compared with control group$(0.55{\pm}0.17)$. Necrotic changes of myeloid cells of BI-G treated group were less severe than those of control group. Histopathologically, distention of sinus and edematous changes of bone marrow of BI-G treated group were alleviated compared with those of control group. In experiment II, the results were as follows ; WBC(${\times}10^3/{\mu}l$) of BI-G treated group(4.27 0.94) was increased significantly compared with control group$(3.02{\pm}0.79)$. Hemoglobin(g/dl) of BI-G treated group$(12.61{\pm}0.85)$ was increased significantly compared with control group$(11.49{\pm}0.74)$. Platelets(${\times}10^3/{\mu}l$) of BI-G treated group$(1885{\pm}133)$ was increased significantly compared with control group$(1616{\pm}251)$. These results indicated that Bojung-ikki-tang Gamibang has the inhibiting and repairing effects on the cyclophosphamide-induced bone marrow injuries in rats.